You are here

  • Home
  • Archive
  • Volume 60, Issue Suppl 1
  • SAT0094 Celecoxib does not increase the risk of cardiac failure, oedema, or hypertension compared to nsaids: results from success 1, a double blind, randomised trial in 13,274 oa patients

Alerts

Article menu
Download PDFPDF
Speaker abstracts 2001
Osteoarthritis – Clinical aspects and treatment
SAT0094 Celecoxib does not increase the risk of cardiac failure, oedema, or hypertension compared to nsaids: results from success 1, a double blind, randomised trial in 13,274 oa patients
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address